- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04684576
Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car
Early Powered Mobility for Toddlers With Cerebral Palsy: A Comparative Case Series of the Permobil® Explorer Mini and a Modified Ride-On Car
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Overview:
This study will examine how early powered mobility devices impact the lives of children with cerebral palsy (CP) and their families. Investigators will compare a modified ride-on car to one specifically designed for children 12-36 months with disabilities to understand how the early introduction of these devices affects the child's developmental outcomes, examine device use patterns (frequency, duration, and environment) and evaluate caregiver perceptions of a motorized mobility device. Research comparing these devices in natural environments will provide critical data regarding early powered mobility for children with CP.
Abstract:
Children diagnosed with CP, or children being monitored for signs and symptoms related to CP, make up the largest group of children affected by a disability. Across the lifespan, many people with CP use powered mobility devices such as scooters and wheelchairs to support their mobility and participation in home and community settings. However, the trend in early intervention has been to delay use of devices until efforts to promote independent walking are exhausted, despite strong evidence that supports early use of powered mobility to assist with participation in everyday activities. Additionally, research has indicated the use of powered mobility complements (rather than detracts from) other interventions focused on more traditional self-initiated mobility skills such as crawling and walking.
Study investigators have been involved in an international mobility and socialization program called Go Baby Go, which provides safety and accessibility modifications to commercially available toy ride-on cars. In compliment to this work, their colleagues at Permobil® have designed and recently received FDA clearance for the Explorer Mini, a powered mobility device specifically designed for children 12-36 months with disabilities such as CP to enhance their mobility and environmental exploration. Both these early powered mobility options offer functional, aesthetic, and affordable alternatives for children and families to fill a gap left by traditional powered wheelchairs.
Investigators are using a mixed-methods study to investigate the device use patterns, caregiver perceptions, and developmental outcomes of children with CP and their families. This represents the first opportunity to compare the novel device (Explorer mini) with a modified ride-on car, which has also been customized to support early self-initiated mobility in a socially inviting way. Taken together, research comparing these devices in natural environments can add critical data to the evidence base supporting early powered mobility for children with CP as a part of using multiple devices for mobility to care for those with disabilities across the lifespan. This study will also create a pilot data set from which to secure future large-scale funding to assess a wider variety of mobility devices with multiple trial sites across the country. Establishing and improving this evidence base for children with CP and their families is essential to ensure equitable access to mobility and participation experiences across the lifespan using a range of technologies to support access and facilitate achievement of key developmental skills. The aims are to: 1) Evaluate a powered mobility intervention to promote developmental, activity and participation outcomes of young children with CP; and 2) Compare the use patterns (frequency, duration, environment) of two powered mobility options: The Explorer Mini and a modified ride-on car.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- Grand Valley State University
-
-
Oregon
-
Corvallis, Oregon, United States, 97330
- Oregon State University
-
-
Washington
-
Seattle, Washington, United States, 98028
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
The child will:
- be between 12-36 months old;
- have a medical diagnosis of CP with any level (I-V) of associated motor ability according to the Gross Motor Function Classification System (GMFCS) or be at risk for CP according to birth history and current developmental status;
- be able to attain a seated position with or without support;
- be able to tolerate upright sitting with or without support while moving through space for 30 minutes;
- live in a household where English is spoken proficiently.
Adults will:
- be 18 years or older and be the legal caregiver for the child participant;
- demonstrate proficiency in English. Inclusion criteria will be secured via caregiver report using screening questions.
Exclusion Criteria:
Child will be excluded if:
- they have not been given a medical diagnosis of CP or are not at risk for CP (per parent report of birth history and current developmental status);
- if they cannot attain a seated position with or without support;
if they cannot tolerate upright sitting with or without support for 30 minutes;
Adult caregivers will be excluded if:
- they are not proficient in English (determined per screening process).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Explorer Mini First (AB Arm)
Children randomized into this arm will first trial a Permobil Explorer Mini powered mobility device over an 8-week intervention period, then trial a modified ride-on car over a second 8-week intervention period in their home and community environments.
|
The use of powered mobility devices for young children with cerebral palsy is increasingly recommended.
The Permobil Explorer Mini is a new pediatric powered wheelchair that has been cleared by the FDA.
The Explorer Mini will be provided for 8-weeks, and families will be provided with suggested use frequencies and provided with support for implementing the device intervention with their child.
Access to commercial powered mobility devices is often limited by funding or size.
Many families use toy ride-on cars for early mobility, which can be easily adapted for safety and accessibility.
The modified ride-on car will be provided for 8-weeks, and families will be provided with suggested use frequencies and provided with support for implementing the device intervention with their child.
|
|
Active Comparator: Modified Ride On Car First (BA Arm)
Children randomized into this arm will first trial a modified ride-on car over an 8-week intervention period, then trial a Permobil Explorer Mini powered mobility device over a second 8-week intervention period in their home and community environments.
|
The use of powered mobility devices for young children with cerebral palsy is increasingly recommended.
The Permobil Explorer Mini is a new pediatric powered wheelchair that has been cleared by the FDA.
The Explorer Mini will be provided for 8-weeks, and families will be provided with suggested use frequencies and provided with support for implementing the device intervention with their child.
Access to commercial powered mobility devices is often limited by funding or size.
Many families use toy ride-on cars for early mobility, which can be easily adapted for safety and accessibility.
The modified ride-on car will be provided for 8-weeks, and families will be provided with suggested use frequencies and provided with support for implementing the device intervention with their child.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Child Developmental Outcomes From Baseline to 8 Weeks
Time Frame: At baseline, after first 8-week device intervention period
|
The Bayley Scales of Infant Development (BSID), 4th Edition is an internationally recognized, norm referenced set of tests designed to assess developmental domains from one month to 42 months of age.
This BSID-IV assessment includes Cognitive, Receptive Communication, Expressive Communication, Gross Motor, and Fine Motor subscales.
Each subscale has unique score value maximums, but on all subscales, higher scores mean a better outcome.
Raw score scales are in increments of 1 and range from: Cognitive (0-81); Receptive Communication (0-42); Expressive Communication (0-37); Gross Motor (0-58); Fine Motor (0-46).
Mean changes in Raw Scores are reported for each domain in this summary.
|
At baseline, after first 8-week device intervention period
|
|
Change in Child Developmental Outcomes From 8 Weeks to 16 Weeks
Time Frame: After second 8-week device intervention period.
|
The Bayley Scales of Infant Development (BSID), 4th Edition is an internationally recognized, norm referenced set of tests designed to assess developmental domains from one month to 42 months of age.
This BSID-IV assessment includes Cognitive, Receptive Communication, Expressive Communication, Gross Motor, and Fine Motor subscales.
Each subscale has unique score value maximums, but on all subscales, higher scores mean a better outcome.
Raw score scales are in increments of 1 and range from: Cognitive (0-81); Receptive Communication (0-42); Expressive Communication (0-37); Gross Motor (0-58); Fine Motor (0-46).
Mean changes in Raw Scores are reported for each domain in this summary.
|
After second 8-week device intervention period.
|
|
Change in Child Developmental Outcomes From Baseline to 16 Weeks
Time Frame: At baseline, and after the second 8-week device period.
|
The Bayley Scales of Infant Development (BSID), 4th Edition is an internationally recognized, norm referenced set of tests designed to assess developmental domains from one month to 42 months of age.
This BSID-IV assessment includes Cognitive, Receptive Communication, Expressive Communication, Gross Motor, and Fine Motor subscales.
Each subscale has unique score value maximums, but on all subscales, higher scores mean a better outcome.
Raw score scales are in increments of 1 and range from: Cognitive (0-81); Receptive Communication (0-42); Expressive Communication (0-37); Gross Motor (0-58); Fine Motor (0-46).
Mean changes in Raw Scores are reported for each domain in this summary.
|
At baseline, and after the second 8-week device period.
|
|
Change in Child Participation and Recreational Activities From Baseline to 8 Weeks
Time Frame: At baseline, after first 8-week device intervention period.
|
Child Engagement in Daily Life (CEDL).
The CEDL is a caregiver survey tool that assesses participation in family and recreational activities and uses a 5-point Likert scale to assess frequency of participation and enjoyment of participation.
The CEDL also assesses participation in self-care behaviors and uses a 5-point Likert scale to assess the degree to which the child participates in the daily self-care activities of feeding, dressing, bathing, and toileting.
Scores are reported for the first section, Frequency of Participation, and the third section, Participation in Self-Care, using scaled scores validated with individuals with CP, which range between 0-100.
For the remaining section (Enjoyment of Participation), only raw scores are reported, with ranges of 11-55, respectively.
Higher or increased scores indicate better outcomes on all scales.
|
At baseline, after first 8-week device intervention period.
|
|
Change in Child Participation and Self-care Activities From 8 Weeks to 16 Weeks
Time Frame: After second 8-week device intervention period.
|
Child Engagement in Daily Life (CEDL).
The CEDL is a caregiver survey tool that assesses participation in family and recreational activities and uses a 5-point Likert scale to assess frequency of participation and enjoyment of participation.
The CEDL also assesses participation in self-care behaviors and uses a 5-point Likert scale to assess the degree to which the child participates in the daily self-care activities of feeding, dressing, bathing, and toileting.
Scores are reported for the first section, Frequency of Participation, and the third section, Participation in Self-Care, using scaled scores validated with individuals with CP, which range between 0-100.
For the remaining section (Enjoyment of Participation), only raw scores are reported, with ranges of 11-55, respectively.
Higher or increased scores indicate better outcomes on all scales.
|
After second 8-week device intervention period.
|
|
Change in Child Participation and Self Care Outcomes From Baseline to 16 Weeks
Time Frame: At baseline, and after the second 8-week device period.
|
Child Engagement in Daily Life (CEDL).
The CEDL is a caregiver survey tool that assesses participation in family and recreational activities and uses a 5-point Likert scale to assess frequency of participation and enjoyment of participation.
The CEDL also assesses participation in self-care behaviors and uses a 5-point Likert scale to assess the degree to which the child participates in the daily self-care activities of feeding, dressing, bathing, and toileting.
Scores are reported for the first section, Frequency of Participation, and the third section, Participation in Self-Care, using scaled scores validated with individuals with CP, which range between 0-100.
For the remaining section (Enjoyment of Participation), only raw scores are reported, with ranges of 11-55, respectively.
Higher or increased scores indicate better outcomes on all scales.
|
At baseline, and after the second 8-week device period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability, Intervention Appropriateness, and Feasibility of The Explorer Mini
Time Frame: After first 8-week device intervention period.
|
Caregivers will complete a 3-measure perceptual implementation outcome survey.
All measures are 4-item, 5-point likert-scale surveys.
The minimum value is 1 and the maximum value is 5 per measure.
The Acceptability of Intervention Measure (AIM) is designed to measure how receptive stakeholders are to adopting an intervention, the Intervention Appropriateness Measure (IAM) is designed to measure suitability of the intervention in a given environment or circumstance, and the Feasibility of Intervention Measure (FIM) is designed to measure how possible and likely stakeholders are to adopt an intervention.
Higher ratings indicate better outcomes, in this case greater acceptability, intervention appropriateness, and feasibility of adoption.
Mean rankings are reported out of a 5 point scale for each section.
|
After first 8-week device intervention period.
|
|
Acceptability, Intervention Appropriateness, and Feasibility of the Ride-On Car
Time Frame: After second 8-week device intervention period.
|
Caregivers will complete a 3-measure perceptual implementation outcome survey.
All measures are 4-item, 5-point likert-scale surveys.
The minimum score is 1 and the maximum score is 5 per measure.
The Acceptability of Intervention Measure (AIM) is designed to measure how receptive stakeholders are to adopting an intervention, the Intervention Appropriateness Measure (IAM) is designed to measure suitability of the intervention in a given environment or circumstance, and the Feasibility of Intervention Measure (FIM) is designed to measure how possible and likely stakeholders are to adopt an intervention.
Higher ratings indicate better outcomes, in this case greater acceptability, intervention appropriateness, and feasibility of adoption.
Mean rankings are reported out of a total maximum of 5 for each section.
|
After second 8-week device intervention period.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Device Use Frequency and Patterns
Time Frame: Through study completion at 16 weeks.
|
Caregivers will complete a driving log that indicates the date, time, and environment of Explorer Mini (A) or modified ride-on car use (B).
Caregivers will also make notes about the child's enjoyment level and general activities while using each device.
To supplement caregiver reported data, automated device use data such as frequency and duration of activation, average speed, and distance traveled, will be collected either via a custom data logger (mounted on the modified ride-on car) or through integrated device systems (built-in to the Explorer Mini).
|
Through study completion at 16 weeks.
|
|
Changes in Caregiver Perceptions of Powered Mobility Devices, Facilitators and Barriers to Use, and Perceptions of Their Child's Developmental Progress Between 8 Weeks and 16 Weeks.
Time Frame: After second 8-week device intervention period.
|
Semi-structured interviews with caregivers using an interview guide will be conducted to understand their experiences using the respective powered mobility devices, barriers encountered and solutions discovered, and perceptions of self-efficacy and behavioral capacity.
|
After second 8-week device intervention period.
|
|
Changes in Caregiver Perceptions of Powered Mobility Devices, Facilitators and Barriers to Use, and Perceptions of Their Child's Developmental Progress Between Baseline and 8 Weeks.
Time Frame: At baseline, after first 8-week device intervention period.
|
Semi-structured interviews with caregivers using an interview guide will be conducted to understand their experiences using the respective powered mobility devices, barriers encountered and solutions discovered, and perceptions of self-efficacy and behavioral capacity.
|
At baseline, after first 8-week device intervention period.
|
|
Change in Child Participation and Environmental Supportiveness From 8 Weeks to 16 Weeks.
Time Frame: After second 8-week device intervention period.
|
Young Children's Participation & Environment Measure (YC-PEM).The YC-PEM is a caregiver survey tool that has 3 sections: home, daycare/preschool, and community, with each section assessing participation and the environment.
For participation items, parents are asked how often their child has participated in different types of activities, how involved their child is when participating in activities of this type, and if parents would like their child's participation to change.
For environment items, parents are asked if specific aspects of the environment facilitate or hinder their child's participation and if specific supports are available and/or adequate to support their child's participation.
|
After second 8-week device intervention period.
|
|
Change in Child Participation and Environmental Supportiveness From Baseline to 8 Weeks.
Time Frame: At baseline, after first 8-week device intervention period.
|
Young Children's Participation & Environment Measure (YC-PEM).The YC-PEM is a caregiver survey tool that has 3 sections: home, daycare/preschool, and community, with each section assessing participation and the environment.
For participation items, parents are asked how often their child has participated in different types of activities, how involved their child is when participating in activities of this type, and if parents would like their child's participation to change.
For environment items, parents are asked if specific aspects of the environment facilitate or hinder their child's participation and if specific supports are available and/or adequate to support their child's participation.
|
At baseline, after first 8-week device intervention period.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heather A Feldner, PT, PhD, PCS, University of Washington
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00011386
- P2CHD101912 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesRecruiting
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
IRCCS Fondazione Stella MarisNot yet recruitingCerebral Palsy (CP) | EEG | Unilateral Cerebral Palsy | Action ObservationItaly
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
Clinical Trials on Permobil Explorer Mini
-
University of WashingtonNational Center for Advancing Translational Sciences (NCATS)CompletedCerebral Palsy | Down Syndrome | Gross Motor DelayUnited States
-
MarsiBionicsHospital General Universitario Gregorio Marañon; Hospital Infantil Universitario... and other collaboratorsActive, not recruitingNeurodevelopmental Disorders | Neuromuscular DisordersSpain
-
Johns Hopkins UniversityEnverdis Corp.TerminatedCoronary Artery Disease | Coronary Heart Disease | Ischemic Heart DiseaseUnited States
-
MarsiBionicsHospital Universitario La PazNot yet recruitingNeuromuscular DisordersSpain
-
Marmara UniversityCompletedCerebral Palsy | Developmental Disability | Development, Infant | Motor Disorders | PrematureTurkey
-
MarsiBionicsHospital Infantil Universitario Niño Jesús, Madrid, Spain; APAC, I.A.P.Not yet recruitingNeurodevelopmental Disorders | Neuromuscular DisordersMexico, Spain
-
MarsiBionicsHospital General Universitario Gregorio Marañon; Hospital Infantil Universitario... and other collaboratorsCompletedCerebral Palsy | Acquired Brain Injury | Neuromuscular Diseases in ChildrenSpain
-
MarsiBionicsHospital General Universitario Gregorio Marañon; Hospital Infantil Universitario... and other collaboratorsCompletedCerebral Palsy | Acquired Brain Injury | Spinal Muscular AtrophySpain
-
University of PennsylvaniaActive, not recruiting
-
Stanford UniversityGoogle LLC.RecruitingGenetic Disease | Cardiomyopathy | Cardiology | Hypertrophic Cardiomyopathy (HCM)United States